Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948

Getting a Vaccine. (n.d.). Retrieved 31 March 2022, from http://www.bccdc.ca/health-info/diseases-conditions/covid-19/covid-19-vaccine/getting-a-vaccine#under12

Tseng, H. F., Ackerson, B. K., Luo, Y., Sy, L. S., Talarico, C. A., Tian, Y., Bruxvoort, K. J., Tubert, J. E., Florea, A., Ku, J. H., Lee, G. S., Choi, S. K., Takhar, H. S., Aragones, M., & Qian, L. (2022). Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nature Medicine, 1–1. https://doi.org/10.1038/s41591-022-01753-y

Ghinwa El Hayek on Twitter. (n.d.). Twitter. Retrieved 4 October 2021, from https://twitter.com/GhinwaHayek/status/1411393046017630212

Gregory, A., & Weale, S. (2021, September 28). Covid: 37% of people have symptoms six months after infection. The Guardian. https://www.theguardian.com/world/2021/sep/28/covid-37-of-people-have-symptoms-six-months-after-infection

Lee Kennedy-Shaffer. (2021, May 6). .@rebeccajk13 and @mlipsitch showed how to use that to estimate efficacy against prevalent infection (https://t.co/LeXxqcumGS). [Tweet]. @LeeKShaffer. https://twitter.com/LeeKShaffer/status/1390322501817880581

More transmissible variant makes vaccinations more crucial, experts say. (2021, June 10). STAT. https://www.statnews.com/2021/06/10/more-transmissible-variant-covid-19-vaccinations-even-more-crucial/

Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00262-0

Diseases, T. L. I. (2021). An exceptional vaccination policy in exceptional circumstances. The Lancet Infectious Diseases, 21(2), 149. https://doi.org/10.1016/S1473-3099(21)00008-6

Betsch, Cornelia, and Philipp Sprengholz. ‘The Human Factor between Airborne Pollen Concentrations and COVID-19 Disease Dynamics’. PsyArXiv, 16 April 2021. https://doi.org/10.31234/osf.io/hw9gf.

A Marm Kilpatrick. (2021, February 9). Vaccine efficacy in blocking infection & transmission (I think) We can now estimate the (minimum) reduction in transmission from the Moderna vaccine. Thread tl;dr Moderna vaccine blocks >90% (87-93%) of infections & 91% (89-94%) of transmission. *Critiques welcome! Https://t.co/GjQIo3v4oe [Tweet]. @DiseaseEcology. https://twitter.com/DiseaseEcology/status/1359213735424872450

Gandhi. M., Beyer. C., Goosby. E., (2020). Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer. SpringerLink. Retrieved from: https://link.springer.com/article/10.1007/s11606-020-06067-8

Wilson, C. (n.d.). Could the coronavirus trigger post-viral fatigue syndromes? New Scientist. Retrieved June 24, 2020, from https://www.newscientist.com/article/mg24632783-400-could-the-coronavirus-trigger-post-viral-fatigue-syndromes/

Wölfel, R., Corman, V.M., Guggemos, W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature (2020). https://doi.org/10.1038/s41586-020-2196-x